| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Luigi Marzio Biasucci | Q57079766 |
| P2093 | author name string | Annalisa Caroli | |
| Chiara Sonnino | |||
| Maria Giulia Marini | |||
| Maria Teresa Cardillo | |||
| Maria L Narducci | |||
| Roberto Galea | |||
| P2860 | cites work | Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study | Q87414232 |
| High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis | Q28219704 | ||
| Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study | Q31143614 | ||
| Intracardiac and extracardiac markers of inflammation during atrial fibrillation | Q33978341 | ||
| A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells | Q34064320 | ||
| Inflammation as a risk factor for atrial fibrillation | Q34543274 | ||
| Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. | Q34575287 | ||
| The role of connexin40 in atrial fibrillation | Q34609014 | ||
| Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets | Q34658801 | ||
| Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study | Q34727157 | ||
| Histological substrate of atrial biopsies in patients with lone atrial fibrillation | Q34742809 | ||
| Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates | Q34754682 | ||
| High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial | Q35756480 | ||
| Electrocardiography of myocarditis revisited: Clinical and prognostic significance of electrocardiographic changes | Q36347543 | ||
| PET imaging of inflammation biomarkers | Q36997603 | ||
| Current concepts in the pathogenesis of atrial fibrillation | Q37382713 | ||
| The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implications | Q37799958 | ||
| Atrial fibrillation pathophysiology: implications for management. | Q37956126 | ||
| A proposal for new clinical concepts in the management of atrial fibrillation | Q38043614 | ||
| Potential therapeutic role of microRNAs in ischemic heart disease. | Q38089400 | ||
| Targeting inflammation: impact on atherothrombosis | Q38170328 | ||
| Molecular basis of funny current (If) in normal and failing human heart. | Q38551800 | ||
| A functional variant in the promoter region regulates the C-reactive protein gene and is a potential candidate for increased risk of atrial fibrillation. | Q39653047 | ||
| Electrical remodelling of chronic atrial fibrillation | Q41666987 | ||
| Targeting inflammatory pathways for the treatment of cardiovascular disease | Q42410556 | ||
| Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). | Q42923039 | ||
| Cholinergic atrial fibrillation in a computer model of a two-dimensional sheet of canine atrial cells with realistic ionic properties | Q43997290 | ||
| Impact of atrial fibrillation on the risk of death: the Framingham Heart Study | Q45222306 | ||
| MicroRNA and myocardial infarction: a mystery turning into glory? | Q46063349 | ||
| Benefits and risks of corticosteroid prophylaxis in adult cardiac surgery: a dose-response meta-analysis | Q46068707 | ||
| High-sensitivity C-reactive protein and parameters of left ventricular dysfunction | Q46201541 | ||
| Inflammation of atrium after cardiac surgery is associated with inhomogeneity of atrial conduction and atrial fibrillation | Q46520746 | ||
| Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation | Q47389216 | ||
| Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation | Q47408270 | ||
| The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication? | Q47630632 | ||
| Interleukin-2 as a predictor of early postoperative atrial fibrillation after cardiopulmonary bypass graft (CABG). | Q47778368 | ||
| Antibodies against myosin in sera of patients with idiopathic paroxysmal atrial fibrillation | Q47880642 | ||
| Effects of sterile pericarditis on connexins 40 and 43 in the atria: correlation with abnormal conduction and atrial arrhythmias. | Q51025232 | ||
| Inflammation effects on the electrical properties of atrial tissue and inducibility of postoperative atrial fibrillation. | Q51213295 | ||
| Inflammation in lone atrial fibrillation. | Q51823220 | ||
| Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion. | Q51830873 | ||
| Myocardial cell death in fibrillating and dilated human right atria. | Q52536924 | ||
| Biochemical predictors of cardiac rhythm at 1 year follow-up in patients with non-valvular atrial fibrillation. | Q53671334 | ||
| Calpains and cytokines in fibrillating human atria. | Q53872038 | ||
| Prognostic impact of hs-CRP and IL-6 in patients undergoing radiofrequency catheter ablation for atrial fibrillation | Q57806696 | ||
| Does Elevated C-Reactive Protein Increase Atrial Fibrillation Risk? | Q58007648 | ||
| Role of tissue C-reactive protein in atrial cardiomyocytes of patients undergoing catheter ablation of atrial fibrillation: pathogenetic implications | Q58230175 | ||
| The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina | Q58230388 | ||
| Downregulation of connexin40 and increased prevalence of atrial arrhythmias in transgenic mice with cardiac-restricted overexpression of tumor necrosis factor | Q59192120 | ||
| C-Reactive Protein is a Risk Indicator for Atrial Fibrillation After Myocardial Revascularization | Q60680958 | ||
| Arrhythmias during acute pericarditis. A prospective study of 100 consecutive cases | Q67770365 | ||
| [Inflammation of the myocardium as an arrhythmia trigger] | Q73792047 | ||
| Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia | Q73936941 | ||
| Evidence for electrical remodelling of the atrial myocardium in patients with atrial fibrillation. A study using the monophasic action potential recording technique | Q74062335 | ||
| Structural correlate of atrial fibrillation in human patients | Q74292163 | ||
| Association of anti-heat shock protein 65 antibodies with development of postoperative atrial fibrillation | Q80332635 | ||
| The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation | Q80492097 | ||
| Atrial fibrillation in a tertiary care multidisciplinary intensive care unit--incidence and risk factors | Q81433958 | ||
| C-reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation | Q81533831 | ||
| Oxidative stress and inflammatory process in patients with atrial fibrillation: the role of left atrium distension | Q81702833 | ||
| Effects of C-reactive protein and the third and fourth components of complement (C3 and C4) on incidence of atrial fibrillation | Q82404894 | ||
| Endothelial Dysfunction and Atrial Fibrillation: What is the Relationship? | Q82503473 | ||
| High‐Sensitivity C‐Reactive Protein as a Predictor of Atrial Fibrillation Recurrence after Primary Circumferential Pulmonary Vein Isolation | Q82526387 | ||
| Prognostic implications of the high-sensitive C-reactive protein in the catheter ablation of atrial fibrillation | Q82881671 | ||
| Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients | Q84199656 | ||
| The effect of sinus rhythm restoration on high-sensitivity C-reactive protein levels and their association with long-term atrial fibrillation recurrence after electrical cardioversion | Q84305787 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| Atrial Fibrillation | Q815819 | ||
| P304 | page(s) | 461-468 | |
| P577 | publication date | 2014-10-01 | |
| P1433 | published in | Texas Heart Institute Journal | Q26841976 |
| P1476 | title | Inflammation and C-reactive protein in atrial fibrillation: cause or effect? | |
| P478 | volume | 41 |
| Q89804827 | Applications of Graphene Quantum Dots in Biomedical Sensors |
| Q89583944 | Associations of Asthma and Asthma Control With Atrial Fibrillation Risk: Results From the Nord-Trøndelag Health Study (HUNT) |
| Q92647612 | Atrial Fibrillation in Patients with Septic Shock: A One-Year Observational Pilot Study |
| Q92481663 | C-reactive protein promotes inflammation through TLR4/NF-κB/TGF-β pathway in HL-1 cells |
| Q101137379 | Canine atrial fibrillation: Pathophysiology, epidemiology and classification |
| Q50996811 | Cilostazol may prevent cardioembolic stroke in patients undergoing antiplatelet therapy. |
| Q90194122 | Cognitive Function and Atrial Fibrillation: From the Strength of Relationship to the Dark Side of Prevention. Is There a Contribution from Sinus Rhythm Restoration and Maintenance? |
| Q51104775 | Elevated calprotectin in patients with atrial fibrillation with and without heart failure. |
| Q47119072 | Fluvastatin therapy could not decrease progression of paroxysmal atrial fibrillation in non-valvular disease patients |
| Q92257991 | Graphene Quantum Dot-Based Electrochemical Immunosensors for Biomedical Applications |
| Q52629500 | Higher High-Sensitivity C Reactive Protein is Associated with Future Premature Ventricular Contraction: a Community Based Prospective Cohort Study. |
| Q33872912 | Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation |
| Q41851985 | Oncostatin M was associated with thrombosis in patients with atrial fibrillation |
| Q42345777 | Pharmacogenetics and precision medicine: Is inflammation a covert threat to effective genotype-based therapy? |
| Q58804181 | Potential Impact of Oral Inflammations on Cardiac Functions and Atrial Fibrillation |
| Q64227623 | Risk factors analysis of nosocomial pneumonia in elderly patients with acute cerebral infraction |
| Q36178661 | Risk of Atrial Fibrillation or Flutter Associated with Periodontitis: A Nationwide, Population-Based, Cohort Study. |
| Q58726183 | Risks of Pneumonia in COPD Patients with New-Onset Atrial Fibrillation |
| Q38486305 | Role of tumor necrosis factor alpha in the pathogenesis of atrial fibrillation: A novel potential therapeutic target? |
| Q93215244 | Therapeutic Approaches Targeting Inflammation in Cardiovascular Disorders |
| Q64135891 | Vaccination and risk of lone atrial fibrillation in the active component United States military |
Search more.